4.4 Article

FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Mechanisms of human FoxP3+ Treg cell development and function in health and disease

M. Attias et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)

Article Veterinary Sciences

Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviour

Franziska Schmid et al.

VETERINARY AND COMPARATIVE ONCOLOGY (2019)

Article Pathology

Tumor Thickness and Modified Clark Level in Canine Cutaneous Melanocytic Tumors

Serenella Silvestri et al.

VETERINARY PATHOLOGY (2019)

Article Genetics & Heredity

Genome-Wide Analysis of Long Non-Coding RNA Profiles in Canine Oral Melanomas

Christophe Hitte et al.

Article Biochemistry & Molecular Biology

UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma

Yochai Wolf et al.

Article Cell Biology

CTLA-4 Immunohistochemistry and Quantitative Image Analysis for Profiling of Human Cancers

Charles Brown et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2019)

Review Biochemistry & Molecular Biology

The expression of FOXP3 and its role in human cancers

Hao Jia et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)

Article Pathology

FoxP3 and IDO in Canine Melanocytic Tumors

Ilaria Porcellato et al.

VETERINARY PATHOLOGY (2019)

Review Veterinary Sciences

A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma

Ramon M. Almela et al.

VETERINARY SCIENCES (2019)

Review Biochemistry & Molecular Biology

Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas

Belen Hernandez et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Oncology

Checkpoint immunotherapy by nivolumab for treatment of metastatic melanoma

Veerendra Koppolu et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)

Article Veterinary Sciences

Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours

K. Sakai et al.

VETERINARY AND COMPARATIVE ONCOLOGY (2018)

Article Multidisciplinary Sciences

Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma

Michihito Tagawa et al.

PLOS ONE (2018)

Review Immunology

The Central Role of Inflammation Associated with Checkpoint Inhibitor Treatments

Cristina Vajaitu et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2018)

Review Hematology

CTLA-4: a moving target in immunotherapy

Behzad Rowshanravan et al.

Article Pathology

Feline Injection-Site Sarcoma: Matrix Remodeling and Prognosis

I. Porcellato et al.

VETERINARY PATHOLOGY (2017)

Review Oncology

The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy

Lieve Brochez et al.

EUROPEAN JOURNAL OF CANCER (2017)

Article Veterinary Sciences

Gene and protein expression of a soluble form of CTLA-4 in a healthy dog

Michihito Tagawa et al.

JOURNAL OF VETERINARY MEDICAL SCIENCE (2017)

Article Multidisciplinary Sciences

Predictors of responses to immune checkpoint blockade in advanced melanoma

N. Jacquelot et al.

NATURE COMMUNICATIONS (2017)

Review Immunology

The regulation of immune tolerance by FOXP3

Ling Lu et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Medical Laboratory Technology

The Immunology of Melanoma

Jennifer S. Ko

CLINICS IN LABORATORY MEDICINE (2017)

Editorial Material Pathology

Mitotic Count and the Field of View Area: Time to Standardize

D. J. Meuten et al.

VETERINARY PATHOLOGY (2016)

Review Immunology

Phenotypical characterization of regulatory T cells in humans and rodents

A. L. Rodriguez-Perea et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)

Review Immunology

IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance

David H. Munn et al.

TRENDS IN IMMUNOLOGY (2016)

Article Immunology

Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors

Maria Isabel Carvalho et al.

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2016)

Article Cell Biology

Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner

Rikke B. Holmgaard et al.

CELL REPORTS (2015)

Review Pharmacology & Pharmacy

The Targeting of Indoleamine 2,3 Dioxygenase -Mediated Immune Escape in Cancer

Trine Zeeberg Iversen et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)

Article Biochemical Research Methods

On non-detects in qPCR data

Matthew N. McCall et al.

BIOINFORMATICS (2014)

Article Dermatology

High expression of FOXP3 in primary melanoma is associated with tumour progression

A. L. Gerber et al.

BRITISH JOURNAL OF DERMATOLOGY (2014)

Article Oncology

Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma

R. Mark Simpson et al.

PIGMENT CELL & MELANOMA RESEARCH (2014)

Article Multidisciplinary Sciences

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov et al.

NATURE (2013)

Review Immunology

Indoleamine 2,3 dioxygenase and metabolic control of immune responses

David H. Munn et al.

TRENDS IN IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

Indoleamine 2,3-dioxygenase, Tregs and Cancer

D. H. Munn

CURRENT MEDICINAL CHEMISTRY (2012)

Article Pathology

Prognostic Evaluation of Ki67 Threshold Value in Canine Oral Melanoma

I. L. Bergin et al.

VETERINARY PATHOLOGY (2011)

Article Medicine, Research & Experimental

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

Madhav D. Sharma et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Veterinary Sciences

Histologic features and clinical outcomes of melanomas of lip, haired skin, and nail bed locations of dogs

Patricia C. Schultheiss

JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2006)

Review Immunology

The three Es of cancer immunoediting

GP Dunn et al.

ANNUAL REVIEW OF IMMUNOLOGY (2004)

Review Immunology

Cancer immunoediting: from immunosurveillance to tumor escape

GP Dunn et al.

NATURE IMMUNOLOGY (2002)